3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
20
Neoplasms
19
Lung Neoplasms
11
Carcinoma, Non-Small-Cell Lung
8
Colorectal Neoplasms
6
Uterine Cervical Neoplasms
5
Prostatic Neoplasms
5
Pancreatic Neoplasms
5
Melanoma
5
Carcinoma, Hepatocellular
5
Brain Neoplasms
5
Skin Neoplasms
4
Ovarian Neoplasms
4
Myelodysplastic Syndromes
4
Leukemia, Myeloid, Acute
4
Triple Negative Breast Neoplasms
3
Neoplasm Metastasis
3
Myeloproliferative Disorders
3
Kidney Neoplasms
3
Head and Neck Neoplasms
3
Esophageal Neoplasms
3
Endometrial Neoplasms
3
Carcinoma, Renal Cell
3
Uveal Melanoma
2
Recurrence
2
Neoplasm, Residual
2
Lymphoma, Non-Hodgkin
2
Lymphoma, B-Cell
2
Lung Diseases
2
Glioma
2
Interventions
Paclitaxel
10
Carboplatin
6
Bevacizumab
5
liposomal doxorubicin
4
Topotecan
3
Cyclophosphamide
3
pembrolizumab
2
oregovomab
2
olaparib
2
niraparib
2
fludarabine
2
Nivolumab
2
Drug Therapy
2
trastuzumab deruxtecan
1
rucaparib
1
ribociclib
1
palbociclib
1
mirvetuximab soravtansine
1
isoquercitrin
1
irinotecan sucrosofate
1
fludarabine phosphate
1
denileukin diftitox
1
anlotinib
1
Tinzaparin
1
Saline Solution
1
Propranolol
1
Preoperative Exercise
1
Platinum
1
Palliative Care
1
Neoadjuvant Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Ovarian Epithelial
×
Blood Specimen Collection
×
90 days
×
Clear all
No trials found.